EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $508,000 | -10.2% | 11,435 | 0.0% | 0.02% | +4.3% |
| Q1 2022 | $566,000 | -28.1% | 11,435 | -26.0% | 0.02% | -17.9% |
| Q4 2021 | $787,000 | -34.7% | 15,455 | -28.5% | 0.03% | -26.3% |
| Q3 2021 | $1,206,000 | +14.2% | 21,617 | -12.4% | 0.04% | +52.0% |
| Q2 2021 | $1,056,000 | +15.4% | 24,673 | +36.1% | 0.02% | +19.0% |
| Q1 2019 | $915,000 | +25.3% | 18,131 | 0.0% | 0.02% | +16.7% |
| Q4 2018 | $730,000 | +93.6% | 18,131 | +233.5% | 0.02% | +125.0% |
| Q3 2018 | $377,000 | -8.3% | 5,436 | 0.0% | 0.01% | -20.0% |
| Q2 2018 | $411,000 | +43.7% | 5,436 | 0.0% | 0.01% | +42.9% |
| Q1 2018 | $286,000 | -64.6% | 5,436 | -64.1% | 0.01% | -63.2% |
| Q4 2017 | $809,000 | +21.1% | 15,135 | +78.8% | 0.02% | +26.7% |
| Q2 2017 | $668,000 | +97.1% | 8,465 | +107.2% | 0.02% | +87.5% |
| Q1 2017 | $339,000 | +4.6% | 4,085 | 0.0% | 0.01% | +14.3% |
| Q4 2016 | $324,000 | – | 4,085 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |